Integra Lifesciences Holdings (NASDAQ: IART) reported Q4 EPS of $0.72, $0.09 better than the analyst estimate of $0.63. Revenue for the quarter came in at $203.5 million versus the consensus estimate of $202 million.

Integra Lifesciences Holdings sees FY2012 EPS of $2.93-$3.06, versus the consensus of $3.04. Integra Lifesciences Holdings sees FY2012 revenue of $820-$835 million, versus the consensus of $832.1 million.

For earnings history and earnings-related data on Integra Lifesciences Holdings (IART) click here.

Earnings Guidance